Amneal launches generic Activella

BRIDGEWATER, N.J. — Amneal Pharmaceuticals on Thursday announced the launch of Lopreeza (estradiol/norethindrone acetate) tablets in 0.5-mg and 1-mg dosage strengths. The product is the first authorized generic of Activella from Novo Nordisk and contains the same formulation of estradiol/norethindrone acetate, according to the company.

 

“With an authorized generic like Lopreeza, pharmacists are able to provide their patients with the same brand products at a lower cost,” stated Amneal co-CEO Chirag Patel. “Consistency is critical in this therapeutic category. Women currently taking Activella can now enjoy continuity of therapy by remaining on the brand product while benefiting from the generic savings.” 

 

Both strengths of the drug are shipping; tablets are sold in 28-count dialpack dispensers. Annual U.S. sales of estradiol/norethindrone acetate tablets totalled $116 million as of August 2014, according to IMS Health data.